Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.

导出 OA

翻译打印收藏纠错

作者： Hans H,Brackmann ^[1] ; Wolfgang,Schramm ^[2] ; Johannes,Oldenburg ^[1] ; Viridiana,Cano ^[3] ; Peter L,Turecek ^[4] ; Claude,Négrier ^[5]

作者单位： Haemophilia Center, Institute of Experimental Haematology and Blood Transfusion, University of Bonn, Bonn, Germany. ^[1] Rudolf Marx-Stiftung für Hämostaseologie, Universität München and Bluterbetreuung Bayern e. V. (BBB) - Germany. ^[2] Shire International GmbH, a Takeda company, Zürich, Switzerland. ^[3] Baxalta Innovations GmbH, a Takeda company, Vienna, Austria. ^[4] Haemophilia and Thrombosis Centre, Louis Pradel Hospital, University Claude Bernard Lyon 1, Lyon, France. ^[5]

主题词血液凝固因子(Blood Coagulation Factors);血友病A(Hemophilia A);人类(Humans)

DOI 10.1055/a-1159-4273

PMID 32717751

发布时间 2023-11-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交